Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial
ISRCTN ISRCTN74277581
ClinicalTrials.gov identifier
Public title Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Adherence therapy can reduce symptoms, increase attitude and satisfaction towards medication treatment
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Thailand
Disease/condition/study domain Schizophrenia
Participants - inclusion criteria 1. Patients diagnosed by a psychiatrist with schizophrenia according to ICD-10 criteria (World Health Organisation ([WHO], 1992)
2. People with schizophrenia who are older than 20 years of age because they have reached the age of maturity legally and can provide consent independently
3. People with schizophrenia who have been assessed by a psychiatrist not involved in this study to determine that they can provide informed consent
4. People with schizophrenia who are residing in Muang Chiang Mai district
Participants - exclusion criteria Patients suffering from organic brain diseases or learning disability
Anticipated start date 01/12/2004
Anticipated end date 31/08/2005
Status of trial Completed
Patient information material
Target number of participants 70
Interventions Treatment group: adherence therapy
Control group: treatment as usual such as medication treatment, group counselling, occupational and recreational therapy
Primary outcome measure(s) Symptoms of schizophrenia measured using the positive and negative syndrome scale
Secondary outcome measure(s) 1. Symptoms of schizophrenia measured using the Global Assessment of Functioning Scale
2. Attitude towards medication measured using the Hogan Drug Attitude Inventory
3. Satisfaction with medication measured using the Satisfaction With Antipsychotic Medication Scale
4. Side effects of medication measured using the Liverpool University Neuroleptic Side Effect Rating Scale
Sources of funding Praboromarajanok Institute of Workforce Development (Thailand)
Trial website
Publications
Contact name Dr  Richard  Gray
  Address P O Box 30
De Crespigny Park
Denmark Hill
  City/town London
  Zip/Postcode SE5 8AF
  Country United Kingdom
  Tel +44 (0)207 848 0139
  Fax +44 (0)207 848 0458
  Email r.gray@iop.kcl.ac.uk
Sponsor The Royal Thai Government
  Address Office of Educational Affairs
Royal Thai Embassy
28 Prince's Gate
  City/town London
  Zip/Postcode SW7 1QF
  Country United Kingdom
  Tel +44 (0)207 584 4538 (5 lines)
  Fax +44 (0)207 823 9896
  Email enquiries@oeathai.org
  Sponsor website: http://www.oeathai.org
Date applied 24/10/2005
Last edited 04/03/2008
Date ISRCTN assigned 26/04/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central